Cargando…
Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model
Schistosomiasis remains a major cause of morbidity in the world. The challenge today is not so much in the clinical management of individual patients, but rather in population-based control of transmission in endemic areas. Despite recent large-scale efforts, such as integrated control programs aime...
Autores principales: | Carvalho-Queiroz, Claudia, Nyakundi, Ruth, Ogongo, Paul, Rikoi, Hitler, Egilmez, Nejat K., Farah, Idle O., Kariuki, Thomas M., LoVerde, Philip T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451692/ https://www.ncbi.nlm.nih.gov/pubmed/26082781 http://dx.doi.org/10.3389/fimmu.2015.00273 |
Ejemplares similares
-
The Road to Elimination: Current State of Schistosomiasis Research and Progress Towards the End Game
por: Ogongo, Paul, et al.
Publicado: (2022) -
Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis
por: Alwan, Sevan N., et al.
Publicado: (2023) -
Rational approach to drug discovery for human schistosomiasis
por: LoVerde, Philip T., et al.
Publicado: (2021) -
Identification and evolution of nuclear receptors in Platyhelminths
por: Wu, Wenjie, et al.
Publicado: (2021) -
Updated knowledge and a proposed nomenclature for nuclear receptors with two DNA binding domains (2DBD-NRs)
por: Wu, Wenjie, et al.
Publicado: (2023)